Kinnate Biopharma Inc

NASDAQ:KNTE   3:59:57 PM EDT
11.41
-0.54 (-4.52%)
Products

Kinnate Biopharma Receives Fast Track Designation From FDA For Kin-2787

Published: 09/21/2022 21:18 GMT
Kinnate Biopharma Inc (KNTE) - Kinnate Biopharma Inc. Receives Fast Track Designation From the U.S. Food and Drug Administration for Kin-2787, an Investigational Pan-raf Inhibitor.